SAN DIEGO, July 9, 2012 /PRNewswire/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the
Company's Chief Executive Officer, Brian M.
Culley, will present at the OneMedForum New York 2012
Emerging Company Finance Conference on Thursday, July 12, 2012 at 9:45 a.m. Eastern time, at the Metropolitan Club
in New York City.
(Logo:
http://photos.prnewswire.com/prnh/20120612/LA22456LOGO-a)
Interested parties can access a live audio webcast and slide
presentation on the ADVENTRX Pharmaceuticals web site at
www.adventrx.com. An archived presentation will be available on the
web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused
on developing proprietary product candidates. The Company's
lead product candidate is ANX-188, a rheologic, antithrombotic and
cytoprotective agent that improves microvascular blood flow and has
potential application in treating a wide range of diseases and
conditions, such as complications arising from sickle cell
disease. More information can be found on the Company's web
site at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals